ADI vs IKT · P/E 61, rev $11.02B vs $215.2M cap
Analog Devices Inc (ADI) versus Inhibikase Therapeutics Inc (IKT) — a side-by-side from cached financials, not a winner call.
Analog Devices Inc (ADI) is a semiconductors company listed on NASDAQ.
Inhibikase Therapeutics Inc (IKT) is a biotechnology company listed on US.
Latest reported ADI revenue for 2025-11-01 was $11.02B. Net income was $2.27B. ADI currently screens at market cap $201.87B and trailing P/E 61.5.
Latest reported IKT revenue for 2026-06-30 was $0. Net income was -$36.0M. IKT currently screens at market cap $215.2M.
ADI currently screens at market cap $201.87B and trailing P/E 61.5. IKT currently screens at market cap $215.2M.
Not investment advice. Open the ADI and IKT stock pages for the full models.
Not investment advice.